CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,105 | -3.4% | 16,806 | +6.9% | 0.00% | 0.0% |
| Q2 2023 | $512,623 | -5.4% | 15,715 | +2.1% | 0.00% | 0.0% |
| Q1 2023 | $541,750 | -86.2% | 15,395 | -82.0% | 0.00% | -80.0% |
| Q4 2022 | $3,914,494 | -86.5% | 85,432 | -85.7% | 0.01% | -85.3% |
| Q3 2022 | $29,032,000 | +872.9% | 599,228 | +689.0% | 0.03% | +1033.3% |
| Q2 2022 | $2,984,000 | +224.3% | 75,949 | +229.3% | 0.00% | +200.0% |
| Q1 2022 | $920,000 | +132.9% | 23,063 | +166.2% | 0.00% | – |
| Q4 2021 | $395,000 | +13.2% | 8,665 | -11.3% | 0.00% | – |
| Q3 2021 | $349,000 | +51.1% | 9,771 | -1.6% | 0.00% | – |
| Q1 2021 | $231,000 | +21.6% | 9,933 | -38.6% | 0.00% | – |
| Q1 2020 | $190,000 | +57.0% | 16,170 | +42.2% | 0.00% | – |
| Q4 2019 | $121,000 | +27.4% | 11,371 | +36.8% | 0.00% | – |
| Q3 2019 | $95,000 | – | 8,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |